Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Labia

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|July 25, 2003
Molecular and biochemical characterization of a novel class A beta-lactamase (HER-1) from Escherichia hermanniiAnne Beauchef-Havard, Guillaume Arlet, Valerie Gautier, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2002
Bacterial and epidemiologic study of the resistance to oxyiminocephalosporins in Escherichia coli in a French hospitalDidier Lepelletier, Jean-Luc Orsonneau, Anny Blin, et al.
FEMS Microbiology Letters|July 20, 2002
BUT-1: a new member in the chromosomal inducible class C beta-lactamases family from a clinical isolate of Buttiauxella spVincent Fihman, Martin Rottman, Yahia Benzerara, et al.
Marine Biotechnology (New York, N.Y.)|February 13, 2004
Antifouling activities of N-substituted imides: antimicrobial activities and inhibition of Mytilus edulis phenoloxidaseFrédéric Zentz, Claire Hellio, Alain Valla, et al.
The Journal of Antimicrobial Chemotherapy|October 15, 2015
A new mechanism to render clinical isolates of Escherichia coli non-susceptible to imipenem: substitutions in the PBP2 penicillin-binding domainNejla Aissa, Noémie Mayer, Fréderic Bert, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 13, 2002
Synthesis and antimicrobial activities of N-substituted imidesFrederic Zentz, Alain Valla, Regis Le Guillou, et al.
Antimicrobial Agents and Chemotherapy|December 26, 2001
Postneurosurgical meningitis due to Proteus penneri with selection of a ceftriaxone-resistant isolate: analysis of chromosomal class A beta-lactamase HugA and its LysR-type regulatory protein HugRNadia Liassine, Stéphanie Madec, Béatrice Ninet, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Structure-activity relationships of methylene or terminal side chain modified retinoids on the differentiation and cell death signaling in NB4 promyelocytic leukemia cellsDiana Ivanova, Aurélie Rossin, Hinrich Gronemeyer, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Survey of Enterobacteriaceae producing extended-spectrum beta-lactamases in a Slovak hospital: dominance of SHV-2a and characterization of TEM-132Martina Zarnayová, Eliane Siebor, André Péchinot, et al.
FEMS Microbiology Letters|June 8, 2002
Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitorsStéphanie Madec, Claudine Blin, Rajagopal Krishnamoorthy, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|July 25, 2003
Molecular and biochemical characterization of a novel class A beta-lactamase (HER-1) from Escherichia hermanniiAnne Beauchef-Havard, Guillaume Arlet, Valerie Gautier, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2002
Bacterial and epidemiologic study of the resistance to oxyiminocephalosporins in Escherichia coli in a French hospitalDidier Lepelletier, Jean-Luc Orsonneau, Anny Blin, et al.
FEMS Microbiology Letters|July 20, 2002
BUT-1: a new member in the chromosomal inducible class C beta-lactamases family from a clinical isolate of Buttiauxella spVincent Fihman, Martin Rottman, Yahia Benzerara, et al.
Marine Biotechnology (New York, N.Y.)|February 13, 2004
Antifouling activities of N-substituted imides: antimicrobial activities and inhibition of Mytilus edulis phenoloxidaseFrédéric Zentz, Claire Hellio, Alain Valla, et al.
The Journal of Antimicrobial Chemotherapy|October 15, 2015
A new mechanism to render clinical isolates of Escherichia coli non-susceptible to imipenem: substitutions in the PBP2 penicillin-binding domainNejla Aissa, Noémie Mayer, Fréderic Bert, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 13, 2002
Synthesis and antimicrobial activities of N-substituted imidesFrederic Zentz, Alain Valla, Regis Le Guillou, et al.
Antimicrobial Agents and Chemotherapy|December 26, 2001
Postneurosurgical meningitis due to Proteus penneri with selection of a ceftriaxone-resistant isolate: analysis of chromosomal class A beta-lactamase HugA and its LysR-type regulatory protein HugRNadia Liassine, Stéphanie Madec, Béatrice Ninet, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Structure-activity relationships of methylene or terminal side chain modified retinoids on the differentiation and cell death signaling in NB4 promyelocytic leukemia cellsDiana Ivanova, Aurélie Rossin, Hinrich Gronemeyer, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Survey of Enterobacteriaceae producing extended-spectrum beta-lactamases in a Slovak hospital: dominance of SHV-2a and characterization of TEM-132Martina Zarnayová, Eliane Siebor, André Péchinot, et al.
FEMS Microbiology Letters|June 8, 2002
Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitorsStéphanie Madec, Claudine Blin, Rajagopal Krishnamoorthy, et al.
Pageof 3